SMARCAL1 and Schimke immuno-osseous dysplasia: Finally, determining the impact (or its absence) of various therapeutic approaches commonly used for SIOD, such as steroid therapy and kidney transplantation, on SMARCAL1’s biological functions could help in developing optimal treatment strategies in the case of SIOD patients with residual SMARCAL1 activity or some retaining functions of this protein.